-
Primary supervisor - Prof Mark Searcey One of the key problems in the development of new anticancer agents is specificity. How do you get the compound to the site of action in the body and avoid
-
neuroprotective effects. Camptothecin – A clinically relevant anticancer agent targeting Topoisomerase I. In collaboration with Prozomix Ltd. (an industrial leader in enzyme development), this project will
-
to prostate cancer progression. This information will support the setting up of a clinical trial where anti-microbial agents are used to prevent prostate cancer development, resulting in significant
Searches related to agent based
Enter an email to receive alerts for agent-based positions